Morgan Stanley lowered the firm’s price target on Ally Financial (ALLY) to $41 from $45 and keeps an Overweight rating on the shares. The firm still sees a path to $6 EPS in 2026, but says that “path likely remains choppy,” adding that the net interest margin, or NIM, expansion story for Ally is “delayed, not derailed.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ALLY:
- Ally Financial upgraded to Market Perform from Underperform at Raymond James
- Netflix reports Q3 beat, CVS CEO Lynch steps down: Morning Buzz
- Ally Financial falls -6.4%
- Unusually active option classes on open October 18th
- Morning Movers: CVS Health sinks following CEO change, weak guidance
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
